iiinova — where your digital self keeps evolving

Ontario Drug Policy Research Network @odprn.bsky.social · 15/10/2026

Explore the new Ontario Medication and Pharmacy Services Dashboard! This dashboard can help track important shifts in medication use and pharmacy services to support Ontario’s healthcare system. Learn more at odprn.ca/ompsd/

010

Ontario Drug Policy Research Network @odprn.bsky.social · 09/10/2026

September data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨There were 207 suspect drug-related deaths reported in September 2026 in Ontario. Data available for download at odprn.ca/occ-opioid-a...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 09/10/2026

The EMS opioid response dashboard has been updated on the Ontario Opioid Indicator Tool with new Q1 2026 data. Learn more at odprn.ca/ontario-opio...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 01/10/2026

Among First Nations Peoples in Ontario, both buprenorphine/naloxone and methadone were effective treatment options for opioid use disorder (OUD). These findings highlight the importance of equitable access to both treatment options. @chiefsofontario.bsky.social odprn.ca/research/pub...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 30/09/2026

On National Day for Truth and Reconciliation, we remain committed to continuing to listen, learn, and take action in response to the Calls to Action through our work. Read our statement below. #NDTR #TruthAndReconciliation #OrangeShirtDay #EveryChildMatters #Reconciliation

000

Ontario Drug Policy Research Network @odprn.bsky.social · 29/09/2026

NEW ODPRN study described trends in law enforcement seizures of opioid-containing pills across Canada Findings revealed substantial fluctuations in the number of counterfeit fentanyl pills seized, highlighting the unpredictable nature of Canada’s unregulated drug supply odprn.ca/research/pub...

001

Ontario Drug Policy Research Network @odprn.bsky.social · 23/09/2026

NEW ODPRN report examines opioid use disorder (OUD) and opioid toxicity harms among older adults in Ontario. Findings show a growing opioid crisis among older adults, with rising trends seen across OUD diagnoses, opioid-related hospital visits, and opioid toxicity death. odprn.ca/research/pub...

002

Ontario Drug Policy Research Network @odprn.bsky.social · 09/09/2026

The ODPRN is now accepting applications for our FREE Drug Policy Student Research Training Program! Trainees involved in this program will have access to online training and networking opportunities with scientific academic researchers and ministry representatives. odprn.ca/student-trai...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 03/09/2026

NEW ODPRN study found that the 2022 pediatric antipyretic shortage did not lead to increased rates of fever-related ED visits or acetaminophen poisoning-related ED visits in either Ontario or Alberta. Learn more at odprn.ca/research/pub...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 31/08/2026

Today on International Overdose Awareness Day, we remember the people we have lost to Canada’s drug toxicity crisis. To mark this day, we're projects and resources that can help to support informed conversations that point toward the kind of change communities are working to build. odprn.ca/ioad/

100

Ontario Drug Policy Research Network @odprn.bsky.social · 17/08/2026

July data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨There were 219 suspect drug-related deaths reported in July 2026 in Ontario. Data available for download at odprn.ca/occ-opioid-a...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 13/08/2026

Patients & Pharmacists Wanted! ⭐ CareMAPRx is conducting virtual interviews to learn more about real-world experiences with pharmacist prescribing. 🔗 Check out the link below for details and eligibility. redcap.its.dal.ca/surveys/?s=H... #pharmacyresearch #patientvoice #pharmacist

000

Ontario Drug Policy Research Network @odprn.bsky.social · 11/08/2026

1 week left until our Town Hall! Participants will reflect on lessons they learned while navigating Patient Support Programs (PSPs), the supports that were most helpful or challenging, and questions they still have. 📅 August 18, 2026 🕛 12:00–1:30 PM ET ca01web.zoom.us/webinar/regi...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 10/08/2026

📸 Construction & Trades snapshot summary. Learn about key findings in the trends and circumstances surrounding opioid toxicity deaths among individuals working in the Construction and Trades sector. Details and information on other sectors can be found at odprn.ca/research/pub...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 06/08/2026

OCC data on opioid-related toxicities in Ontario is now available for 2026 Q1. Update includes: - Trends in opioid-related deaths over time, stratified by age, sex, and substances involved. - # of opioid-related deaths by Public Health Unit and Census Subdivision. odprn.ca/occ-opioid-a...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 27/07/2026

Join us for our upcoming Town Hall as we explore the experiences of people with long-term chronic conditions as well as their family/caregivers who have interacted with Patient Support Programs (PSPs). 📅 August 18, 2026 🕛 12:00–1:30 PM ET 🔗 odprn.ca/town-halls

000

Ontario Drug Policy Research Network @odprn.bsky.social · 22/07/2026

NEW report examines the difference in opioid-related harms across occupations in Ontario. Opioid toxicity death rates vary across occupational sectors in Ontario, with the highest burden observed among workers in Construction & Trades and Natural Resources & Agriculture. odprn.ca/research/pub...

010

Ontario Drug Policy Research Network @odprn.bsky.social · 21/07/2026

Who’s RxReady for drug policy and research? RxReady is a FREE, self-paced, online course designed to make drug policy and research concepts accessible to anyone interested in understanding how medications are studied, regulated, funded, and used in Canada. Learn more at www.odprn.ca/RxReady

000

Ontario Drug Policy Research Network @odprn.bsky.social · 17/07/2026

Patient Support Programs (PSPs) are services designed to help patients access and manage their medications. Our upcoming Town Hall will explore experiences of those with long-term chronic conditions who have interacted with PSPs. 📅 August 18, 2026 🕛 12:00–1:30 PM ET Register at odprn.ca/town-halls

000

Ontario Drug Policy Research Network @odprn.bsky.social · 13/07/2026

New free learning opportunity! RxReady is a free, online training course for anyone interested in learning more about drug policy, regulation, and research in Canada. Learn about drugs, drug policy, research, the role of patient partners, and real-world case examples. www.odprn.ca/RxReady

000

Ontario Drug Policy Research Network @odprn.bsky.social · 10/07/2026

June data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨There were 225 suspect drug-related deaths reported in June 2026 in Ontario. Data available for download at odprn.ca/occ-opioid-a...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 09/07/2026

Upcoming Town Hall: Experiences with Patient Support Programs (PSPs) in Healthcare People living with long-term chronic conditions are invited to share their experiences, perspectives, & questions about PSPs 📅 August 18, 2026 🕛 12 – 1:30 PM ET Learn more and register at odprn.ca/town-halls/ 1/3

100

Ontario Drug Policy Research Network @odprn.bsky.social · 02/07/2026

📰 The latest edition of ODPRN's Quarterly Newsletter is now available! Here’s what the ODPRN was up to this past Spring and what is coming up this Summer. odprn.ca/newsletters/

000

Ontario Drug Policy Research Network @odprn.bsky.social · 30/06/2026

Upcoming Pharmaceutical Sciences Seminar Effective approaches to address unprecedented rates of death arising from the unregulated drug supply: Recent insights from British Columbia, 10 years after the declaration of a public health emergency 📅 Thursday, July 9, 2026 🕥 10:30 a.m. 📍 PB-850

000

Ontario Drug Policy Research Network @odprn.bsky.social · 24/06/2026

New study shows that small changes in how benzodiazepines are prescribed can help prevent long-term use. Using shorter treatment courses, prescribing only one benzodiazepine, and choosing short-acting options were all linked to a lower risk of long-term use. Learn more at odprn.ca/research/pub...

010

Ontario Drug Policy Research Network @odprn.bsky.social · 15/06/2026

May data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨There were 217 suspect drug-related deaths reported in May 2026 in Ontario. Data available for download at odprn.ca/occ-opioid-a...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 05/06/2026

New update to our Opioid Indicator Tool! This update includes 2025 annual data, as well as monthly/quarterly data up to December 2025. The Harm Reduction dashboard also includes data for Q1 2026. Learn more at odprn.ca/ontario-opio...

010

Ontario Drug Policy Research Network @odprn.bsky.social · 04/06/2026

NEW ODPRN study on opioid agonist therapy (OAT) use among First Nation Peoples in Ontario highlights evolving treatment patterns and access to care over the past decade. Learn more at odprn.ca/research/pub...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 02/06/2026

NEW ODPRN study found that among older adults with insulin-treated diabetes in Ontario, immigrants were less likely than long-term residents to start using publicly funded flash glucose monitoring systems despite universal coverage. Learn more at odprn.ca/research/pub...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 22/05/2026

NEW ODPRN Town Hall report on the growing use of Sublocade as a treatment option for opioid use disorder. Read the report + listen to the audio clips from 4 of the individuals who shared live during the Town Hall. odprn.ca/town-halls/s...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 19/05/2026

April data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨There were 210 suspect drug-related deaths reported in April 2026 in Ontario. Data available for download at odprn.ca/occ-opioid-a...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 19/05/2026

The ODPRN is currently seeking an epidemiologist for a 12-month temporary full time position. In this role, you will work collaboratively with other members of the ODPRN to develop research proposals and analysis plans for the research team. Learn more and apply at lnkd.in/etsMw6zK

000

Ontario Drug Policy Research Network @odprn.bsky.social · 11/05/2026

New quarterly summary and census subdivision data on #opioid-related deaths in #Ontario from the OCC for 2025 Q4 is now available. Note that the decrease in Q1&Q2 2025 reflects the continuation of a trend that began in Q3 2024. Data available for download at odprn.ca/occ-opioid-a...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 20/04/2026

New update to our Opioid Indicator Tool! This update includes data up to Q3 2025 and incorporates merged PHU data to reflect the 2025 PHU mergers. Learn more at odprn.ca/ontario-opio...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 13/04/2026

March data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨There were 208 suspect drug-related deaths reported in March 2026 in Ontario. Data available for download at odprn.ca/occ-opioid-a...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 10/04/2026

Upcoming webinar with CATIE and CanHepC will explore how recent changes are affecting harm reduction services and what can be done to support this public health response. 📅 April 20, 2026 🕐 1 to 2:30 p.m. EDT Register at www.catie.ca/harm-reducti...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 09/04/2026

New ODPRN study found early methadone dose titration was associated with improved treatment retention and lower hazard of opioid toxicity. Learn more at odprn.ca/research/pub...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 07/04/2026

New ODPRN study finds a 3-fold increased risk of opioid toxicity when CYP3A4-inhibiting macrolides (clarithromycin, erythromycin) are used with opioids. Learn more at odprn.ca/research/pub... @icesontario.bsky.social @unityhealthto.bsky.social

000

Ontario Drug Policy Research Network @odprn.bsky.social · 23/03/2026

NEW ODPRN study found increased uptake of safer opioid supply (SOS) among First Nations Peoples in Ontario, with the highest rates among those aged 25 - 44 and those living outside of First Nations communities and in urban areas. Learn more at odprn.ca/research/pub...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 11/03/2026

New ODPRN study found RAPID uptake of Flash Glucose Monitoring system among both immigrants and long-term residents in the first few months of this product becoming publicly funded. odprn.ca/research/pub...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 09/03/2026

NEW ODPRN study found that prescriptions for stimulant medications for adults in Ontario increased during COVID-19. People starting these medications were more likely to be women and adults aged 25–34, and less likely to have their prescriptions initiated by psychiatrists. odprn.ca/research/pub...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 06/03/2026

New ODPRN study shows opioid agonist therapy use in Canada increased between 2018 and 2022, especially in rural areas & in provinces experiencing rising opioid-related harms. We also saw differences in access across provinces & a growing shift toward buprenorphine treatment. odprn.ca/research/pub...

001

Ontario Drug Policy Research Network @odprn.bsky.social · 02/03/2026

📣Upcoming Webinar Alert! Making Research Matter: Approaches to Strengthen Connections between Research, Policy, and Community 📅 Tuesday, April 7 2026 | 1 - 2:30pm EST 🔗 Register: www.nihs.pharmacy.utoronto.ca/events-news/... Hosted by the Network for Improving Health Systems (NIHS) & the ODPRN

010

Ontario Drug Policy Research Network @odprn.bsky.social · 17/02/2026

January data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨There were 224 suspect drug-related deaths reported in January 2026 in Ontario. Data available for download at odprn.ca/occ-opioid-a...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 11/02/2026

Today, on the International Day of Women and Girls in Science, the ODPRN recognizes and celebrates the incredible contributions of women on our team and across the research and scientific community. 👩‍🔬 www.womeninscienceday.org #WomenInScience #IDWGS #HealthResearch #EvidenceInformed #ODPRN

000

Ontario Drug Policy Research Network @odprn.bsky.social · 28/01/2026

New ODPRN study finds Ontario’s biosimilar policy achieved high biosimilar uptake and substantial cost savings, with most savings attributed to non-insulin biosimilars. Learn more at odprn.ca/research/pub...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 14/01/2026

NEW ODPRN study found that across Canada, there was significant growth in fentanyl-containing drug seizures with multiple substances detected – most notably benzodiazepines, xylazine and potent fentanyl analogues within a single sample. Learn more at odprn.ca/research/pub...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 12/01/2026

NEW ODPRN study shows the increasing role of the potent, unregulated drug supply in opioid toxicities across Canada and explores how prescription opioid–related harms vary by population group, location, and opioid use. odprn.ca/research/pub...

101

Ontario Drug Policy Research Network @odprn.bsky.social · 12/01/2026

December data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨There were 232 suspect drug-related deaths reported in December 2025 in Ontario. Data available for download at odprn.ca/occ-opioid-a...

000

Ontario Drug Policy Research Network @odprn.bsky.social · 23/12/2025

As we close out the year, we’re sharing our latest quarterly newsletter—a year in review of ODPRN’s work and the collaborations that made it possible. Thank you to our community for your continued engagement and commitment to evidence-informed policy and practice. mailchi.mp/9b99aac00060...

000